When does micafungin’s patent protection expire in Europe?
I can’t give a specific “micafungin patent expiry date in Europe” from the information provided here. Patent end dates for micafungin depend on the specific product and jurisdictional assets (the basic patent vs. any SPC/exclusivity extensions), and different patents can expire on different dates across EU countries.
What exactly can expire (and why the date can differ)?
For an EU market, the end of exclusivity can come from different legal layers:
- The underlying European patent (end of its term).
- A Supplementary Protection Certificate (SPC), if granted, which can extend protection beyond the patent’s normal expiry.
- Other forms of regulatory exclusivity (which are separate from patent expiry and can vary by product and authorization pathway).
Because the result depends on which “micafungin” you mean (brand vs. generic maker, and which authorizations/patents are asserted), you need the exact reference (e.g., the marketing authorization/brand name and the patent family).
How to find the exact EU expiry date for your micafungin version
To get the precise expiry date, use one or more of these sources for the micafungin SPC and the underlying EP patents:
- The EMA/European register data for the specific marketing authorization (to identify the exact product).
- National or EU patent/SPC registers that list:
- SPC grant and expiry dates (if an SPC exists),
- the underlying patent numbers in the same family.
- “Patent expiry” lists are often generic summaries; they can be wrong if they don’t match the specific SPC or patent family.
Does SPC expiry usually control “when generics can launch” in Europe?
Often, the SPC is what matters for “commercial launch timing,” because it can extend market exclusivity after the base patent’s term. Even if one patent expires, another related patent or an SPC can still block supply or licensing. That is why two products that both say “micafungin” can have different practical timelines.
If you’re planning market entry: what to check beyond expiry dates
When assessing entry risk in Europe, it’s not enough to look only at a single expiry date:
- whether there is an SPC and its exact expiration date,
- whether any other later-expiring patents still cover the relevant use/compound form,
- whether there are pending oppositions, litigation, or regulatory stays.
If you share one detail, I can narrow it to an exact date
Tell me:
1) the brand name or marketing authorization name you mean (or the company/product), and
2) whether you want expiry for a specific EU country (e.g., UK is different from EU/EEA after Brexit),
and I’ll map the relevant patent/SPC expiry date for that specific micafungin product in Europe.
Sources
None provided.